Search

Your search keyword '"Nadal, E."' showing total 11 results

Search Constraints

Start Over You searched for: Author "Nadal, E." Remove constraint Author: "Nadal, E." Journal lung cancer amsterdam netherlands Remove constraint Journal: lung cancer amsterdam netherlands
11 results on '"Nadal, E."'

Search Results

1. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

2. Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence.

3. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes.

4. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

5. A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.

6. On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma.

7. Lung cancer patients with COVID-19 in Spain: GRAVID study.

8. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.

9. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.

10. Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease.

11. Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.

Catalog

Books, media, physical & digital resources